6508 A randomized phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer (AGC): a preliminary safety results

J.A.Yun; J.H.Kong; J.A.Kim; S.H.Lee; J.Y.Lee; S.H.Park; J.O.Park; Y.S.Park; H.Y.Lim; W.K.Kang

首页> 外文期刊>European Journal of Cancer Supplements >6508 A randomized phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer (AGC): a preliminary safety results

【24h】

6508 A randomized phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer (AGC): a preliminary safety results

机译：6508在晚期胃癌（AGC）中联合表柔比星，顺铂和卡培他滨（ECX）或顺铂和卡培他滨（CX）联合化疗的II期随机研究

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements 》 |2009年第2期| 共1页
作者
J.A.Yun; J.H.Kong; J.A.Kim; S.H.Lee; J.Y.Lee; S.H.Park; J.O.Park; Y.S.Park; H.Y.Lim; W.K.Kang;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. 6508 A randomized phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer (AGC): a preliminary safety results [J] . J.A.Yun, J.H.Kong, J.A.Kim, European Journal of Cancer Supplements . 2009 ,第2期

机译：6508在晚期胃癌（AGC）中联合表柔比星，顺铂和卡培他滨（ECX）或顺铂和卡培他滨（CX）联合化疗的II期随机研究
2. A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer. [J] . Yun J, Lee J, Park SH, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2010 ,第5期

机译：联合化疗联合表柔比星，顺铂和卡培他滨（ECX）或顺铂和卡培他滨（CX）治疗晚期胃癌的II期随机研究。
3. Matuzumab plus epirubicin, cisplatin and capecitabine (ECX) compared with epirubicin, cisplatin and capecitabine alone as first-line treatment in patients with advanced oesophago-gastric cancer: a randomised, multicentre open-label phase II study. [J] . Rao S, Starling N, Cunningham D, Annals of oncology: official journal of the European Society for Medical Oncology . 2010 ,第11期

机译：马妥珠单抗联合表柔比星，顺铂和卡培他滨（ECX）与表柔比星，顺铂和卡培他滨单独作为晚期食管胃癌患者的一线治疗：一项随机，多中心，开放标签的II期研究。
4. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
5. Randomized Open‐Label Phase II Study Comparing Capecitabine‐Cisplatin Every 3 Weeks with S‐1‐Cisplatin Every 5 Weeks in Chemotherapy‐Naïve Patients with HER2‐Negative Advanced Gastric Cancer: OGSG1105 HERBIS‐4A Trial [O] . Hisato Kawakami, *, Atsushi Takeno, 2018

机译：随机开放标签II期研究比较了未经化疗的HER2阴性晚期胃癌患者每3周将卡培他滨-顺铂与S-1-顺铂每5周进行一次的比较：OGSG1105HERBIS-4A试验
6. A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin(XP) and S-1 plus cisplatin(SP) as a first-line treatment for advanced gastric cancer : XP ascertainment vs. SP randomized PII trial (XParTS II) [O] . Tsuburaya, Akira Tsuburaya, Morita, Satoshi, Kodera, Yasuhiro, 2012

机译：一项II期临床试验，以阐明卡培他滨加顺铂（XP）和S-1加顺铂（SP）作为晚期胃癌的一线治疗的有效性：XP确定性与SP随机PII试验（XParTS II）

6508 A randomized phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer (AGC): a preliminary safety results

著录项

相似文献

相关主题

期刊订阅